Survey Finds Public Confusion About Tylenol Use During Pregnancy and Autism Claims

A recent survey conducted by the Kaiser Family Foundation (KFF) reveals that claims linking Tylenol use during pregnancy to autism have reached most American adults, with only about one-third confidently identifying these claims as false.

The survey, which polled more than 1,000 adults, found that 77% of Americans have heard the Trump administration’s recent warnings about acetaminophen (Tylenol) use during pregnancy. Despite leading medical organizations rejecting these claims, public perception remains notably mixed.

Only 4% of respondents believe the claims are “definitely true,” but the majority fall somewhere in the middle. Approximately 30% consider the claims “probably true,” while another 30% believe they are “probably false.” Just 35% of all adults—and even fewer parents at 32%—confidently identified these claims as “definitely false.”

The findings highlight a concerning gap in public health education at a time when trust in federal health agencies is declining.

“Today’s announcement by HHS is not backed by the full body of scientific evidence and dangerously simplifies the many and complex causes of neurologic challenges in children,” stated Steven J. Fleischman, MD, MBA, president of the American College of Obstetricians and Gynecologists (ACOG), in response to the administration’s claims.

ACOG has consistently endorsed acetaminophen use during pregnancy when medically indicated. Similarly, the American Academy of Pediatrics (AAP) has pushed back against misinformation, stating that “decades of research have found that acetaminophen is safe for children when administered as recommended.”

The AAP further warned that “misleading claims that the medicine is not safe and is linked to increased rates of autism send a confusing, dangerous message to parents and expectant parents and does a disservice to autistic individuals.”

The survey results come amid a broader decline in public trust of federal health agencies. Trust in the Centers for Disease Control and Prevention (CDC) regarding vaccine policy has dropped from 63% in September 2023 to an all-time low of 50% currently.

In contrast, medical professional societies are experiencing growing public confidence. The AAP enjoys 69% trust among parents, while the American Medical Association maintains 64% trust among all adults surveyed.

“It’s encouraging if far from ideal that as trust in our nation’s scientific agencies crumbles, the public does trust the professional associations who have stepped forward,” noted KFF President and CEO Drew Altman.

This shifting landscape of trust presents both challenges and opportunities for healthcare providers. Medical professionals now face increased responsibility to serve as reliable public health messengers, particularly as misinformation spreads rapidly through various channels.

Experts suggest that healthcare providers should leverage their direct patient relationships to address health misinformation. Effective strategies include using empathic communication, acknowledging patients’ concerns, and providing evidence-based alternatives to problematic claims.

The KFF survey underscores the urgent need for coordinated efforts among medical professionals to provide clear, consistent messaging on important public health matters like medication safety during pregnancy.

As public health communication continues to evolve in a polarized information environment, the medical community’s role in providing accurate, trusted guidance becomes increasingly vital for patient safety and population health outcomes.